Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TScan Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 633K | Jun 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRX | TScan Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Dec 27, 2022 | 2 | $9.22K | 4 | Dec 29, 2022 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Mar 24, 2022 | 1 | $51K | 4 | Mar 28, 2022 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Sep 21, 2021 | 1 | $31.6K | 4 | Sep 22, 2021 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Sep 9, 2021 | 1 | $49.9K | 4 | Sep 13, 2021 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Jul 15, 2021 | 1 | $15K | 4 | Jul 22, 2021 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 16, 2021 | Chief Financial Officer |
TCRX | TScan Therapeutics, Inc. | Jul 15, 2021 | 0 | $0 | 3 | Jul 15, 2021 | Chief Financial Officer |